You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 21, December 1, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Nutritional and Metabolic Disorders, Other
 •Women's Health
 •Women's Health, Other
 •Gastroenterology
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vitamin K Deficiency and Hepatocellular Carcinoma

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Habu and colleagues1 suggests that vitamin K2 (menaquinone) supplementation prevents hepatocellular carcinoma in women with viral cirrhosis of the liver. Supplementation would be expected to be more beneficial in patients who have a vitamin K deficiency at the onset of the study, but the vitamin K status of the patients was not reported.

There are 2 plausible mechanisms that could lead to a vitamin K deficiency in patients with cirrhosis. First, because vitamin K is mainly produced by the gut microflora, a deficiency is known to occur in patients receiving broad-spectrum antibiotics.2 Antibiotic prophylaxis is routinely used to prevent bacterial infections in patients with decompensated cirrhosis of the liver. Second, because vitamin K stores are located in the liver, advanced cirrhosis could account for a vitamin K deficiency.

The importance of a low serum albumin level as a prognostic factor for hepatocellular carcinoma . . . [Full Text of this Article]

Marie-Astrid Piquet, MD
piquet-ma@chu-caen.fr

Isabelle Hourmand-Ollivier, MD; Thông Dao, MD
Department of Hepatology and Nutrition
University Hospital
Caen, France



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Vitamin K Deficiency and Hepatocellular Carcinoma—Reply
Daiki Habu, Susumu Shiomi, Takashi Tanaka, and Shuhei Nishiguchi
JAMA. 2004;292(21):2581.
EXTRACT | FULL TEXT  

Role of Vitamin K2 in the Development of Hepatocellular Carcinoma in Women With Viral Cirrhosis of the Liver
Daiki Habu, Susumu Shiomi, Akihiro Tamori, Tadashi Takeda, Takashi Tanaka, Shoji Kubo, and Shuhei Nishiguchi
JAMA. 2004;292(3):358-361.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.